Literature DB >> 32199212

Drivers and regulators of humoral innate immune responses to infection and cancer.

Deepak Kumar1, Yeni Romero2, Kaitlynn N Schuck1, Haley Smalley3, Bibek Subedi3, Sherry D Fleming4.   

Abstract

The complement cascade consists of cell bound and serum proteins acting together to protect the host from pathogens, remove cancerous cells and effectively links innate and adaptive immune responses. Despite its usefulness in microbial neutralization and clearance of cancerous cells, excessive complement activation causes an immune imbalance and tissue damage in the host. Hence, a series of complement regulatory proteins present at a higher concentration in blood plasma and on cell surfaces tightly regulate the cascade. The complement cascade can be initiated by B-1 B cell production of natural antibodies. Natural antibodies arise spontaneously without any known exogenous antigenic or microbial stimulus and protect against invading pathogens, clear apoptotic cells, provide tissue homeostasis, and modulate adaptive immune functions. Natural IgM antibodies recognize microbial and cancer antigens and serve as an activator of complement mediated lysis. This review will discuss advances in complement activation and regulation in bacterial and viral infections, and cancer. We will also explore the crosstalk of natural antibodies with bacterial populations and cancer.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  B-1 B cells; Bacteria; Cancer; Complement; Natural antibodies; Virus

Mesh:

Substances:

Year:  2020        PMID: 32199212      PMCID: PMC7207242          DOI: 10.1016/j.molimm.2020.03.005

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  180 in total

Review 1.  B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory".

Authors:  F Martin; J F Kearney
Journal:  Immunol Rev       Date:  2000-06       Impact factor: 12.988

2.  Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens.

Authors:  F Martin; A M Oliver; J F Kearney
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

3.  Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy.

Authors:  Chuanliang Xu; Monika Jung; Mick Burkhardt; Carsten Stephan; Dietmar Schnorr; Stefan Loening; Klaus Jung; Manfred Dietel; Glen Kristiansen
Journal:  Prostate       Date:  2005-02-15       Impact factor: 4.104

Review 4.  Targeting complement-mediated immunoregulation for cancer immunotherapy.

Authors:  Martin Kolev; Maciej M Markiewski
Journal:  Semin Immunol       Date:  2018-02-15       Impact factor: 11.130

5.  Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer.

Authors:  Yang Su; Yue Liu; Christopher R Behrens; Scott Bidlingmaier; Nam-Kyung Lee; Rahul Aggarwal; Daniel W Sherbenou; Alma L Burlingame; Byron C Hann; Jeffry P Simko; Gayatri Premasekharan; Pamela L Paris; Marc A Shuman; Youngho Seo; Eric J Small; Bin Liu
Journal:  JCI Insight       Date:  2018-09-06

6.  Interaction of Mycoplasma pneumoniae with erythrocyte glycolipids of I and i antigen types.

Authors:  L M Loomes; K Uemura; T Feizi
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

7.  C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells.

Authors:  Bruno Douradinha; Sean P McBurney; Klecia M Soares de Melo; Amanda P Smith; Neel K Krishna; Simon M Barratt-Boyes; Jared D Evans; Eduardo J M Nascimento; Ernesto T A Marques
Journal:  Virus Res       Date:  2013-11-15       Impact factor: 3.303

8.  Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors.

Authors:  Marcin Okroj; Yi-Fan Hsu; Daniel Ajona; Ruben Pio; Anna M Blom
Journal:  Mol Immunol       Date:  2007-06-04       Impact factor: 4.407

9.  C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation.

Authors:  Leendert A Trouw; Sara C Nilsson; Isabel Gonçalves; Göran Landberg; Anna M Blom
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

10.  Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf expression.

Authors:  Kyoko Hayakawa; Anthony M Formica; Joni Brill-Dashoff; Susan A Shinton; Daiju Ichikawa; Yan Zhou; Herbert C Morse; Richard R Hardy
Journal:  J Exp Med       Date:  2016-11-29       Impact factor: 14.307

View more
  3 in total

1.  Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.

Authors:  Qunying Han; Huan Deng; Xiude Fan; Xiaoyun Wang; Xiaoge Zhang; Kun Zhang; Na Li; Yi Lv; Zhengwen Liu
Journal:  J Hepatocell Carcinoma       Date:  2021-11-13

2.  How Children Are Protected From COVID-19? A Historical, Clinical, and Pathophysiological Approach to Address COVID-19 Susceptibility.

Authors:  Magdalena Anna Massalska; Hans-Jürgen Gober
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

Review 3.  The Forgotten Brother: The Innate-like B1 Cell in Multiple Sclerosis.

Authors:  Saar T Halperin; Bert A 't Hart; Antonio Luchicchi; Geert J Schenk
Journal:  Biomedicines       Date:  2022-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.